
ORMP Competitors
Oramed Pharmaceuticals Inc.
$3.89
+$0.02(+0.52%)
56
Overall
80
Value
45
Tech
44
Quality
Market Cap
$168.29M
Volume
164.34K
52W Range
$2.25 - $5.47
Target Price
$7.00
ORMP competitors: RARE, CGEN, SNY, NVO, LXRX. Oramed Pharmaceuticals Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ORMP Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical Inc. | $17.39 | $1.70B | $-3.21 | - | 45 |
| CGEN Compugen Ltd. | $2.02 | $191.06M | $-0.28 | - | 59 |
| SNY Sanofi | $47.16 | $115.92B | $5.07 | 5.13% | 76 |
| NVO Novo Nordisk A/S | $39.39 | $180.22B | $3.38 | 4.71% | 68 |
| LXRX Lexicon Pharmaceuticals, Inc. | $1.72 | $792.52M | $-0.16 | - | 49 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORMP | $3.89 | +0.5% | 164.34K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Oramed Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW